臺大學術典藏 |
2020-04-22T07:09:04Z |
Structural relaxation of adlayers in the presence of adsorbate-induced reconstruction: C60/Cu(111)
|
Tang, T.B.; Lin, K.C.; Hsu, C.-L.; Lin, M.C.; Pai, W.W. |
臺大學術典藏 |
2020-04-22T07:09:04Z |
Aperiodic incommensurate phase of a C60 monolayer on Ag(100)
|
Hsu, C.-L.; Pai, W.W. |
臺大學術典藏 |
2020-04-22T07:08:56Z |
Ordering of an incommensurate molecular layer with adsorbate-induced reconstruction: C60/Ag(100)
|
Pai, W.; Hsu, C.-L. |
臺大學術典藏 |
2020-04-22T07:08:56Z |
Origin of peculiar STM molecular contrast in C60/Ag(100)
|
Pai, W.W.; Hsu, C.-L.; Chiang, C.R.; Chang, Y.; Lin, K.C. |
臺大學術典藏 |
2020-04-16T02:34:53Z |
Pulse analysis system with a novice periodic function examination method on sepsis survival prediction
|
Wu, Z.-H.; Yang, C.-J.; Liao, Z.-K.; Lai, F.; Hsu, C.-L.; Sun, W.-Z.; FEI-PEI LAI; Chen, W.;Wu, Z.-H.;Yang, C.-J.;Liao, Z.-K.;Lai, F.;Hsu, C.-L.;Sun, W.-Z.; Chen, W. |
臺大學術典藏 |
2020-04-10T12:51:00Z |
Development of a PD-L1-expressing orthotopic liver cancer model: Implications for immunotherapy for hepatocellular carcinoma
|
Ou D.-L.;Lin Y.-Y.;Hsu C.-L.;Lin Y.-Y.;Chen C.-W.;Yu J.-S.;Miaw S.-C.;Hsu P.-N.;Cheng A.-L.;Chiun Hsu; Ou D.-L.; Lin Y.-Y.; Hsu C.-L.; Lin Y.-Y.; Chen C.-W.; Yu J.-S.; Miaw S.-C.; Hsu P.-N.; Cheng A.-L.; Chiun Hsu |
臺大學術典藏 |
2020-04-07T07:00:53Z |
Increased Risk of Acute Cholecystitis in Patients With Spinal Cord Injury: A Nationwide Population-Based Cohort Study
|
Hsu C.-L.; Wang M.-T.; Ho Y.-C.; SHIN-LIANG PAN; Hsu C.-L.;Wang M.-T.;Ho Y.-C.;Shin-Liang Pan |
臺大學術典藏 |
2020-04-07T07:00:53Z |
Spinal cord injury and Alzheimer's disease risk: A population-based, retrospective cohort study article
|
SHIN-LIANG PAN; Hsu C.-L.; Ho Y.-C.; Yeh T.-S.;Ho Y.-C.;Hsu C.-L.;Shin-Liang Pan; Yeh T.-S. |
臺大學術典藏 |
2020-03-31T08:54:40Z |
Adding moxifloxacin is associated with a shorter time to culture conversion in pulmonary tuberculosis
|
Yang P.-C.; LI-NA LEE; Hsueh P.-R.; Yu C.-J.; Hsu C.-L.; Tsai T.-H.; Wang J.-T.; Wang J.-Y. |
臺大學術典藏 |
2020-03-31T08:54:37Z |
Clinical characteristics and prognosis of nontuberculous mycobacterial lung disease with different radiographic patterns
|
LI-NA LEE; Yu C.-J.; Shu C.-C.; Lee C.-H.; Hsu C.-L.; Wang J.-T.; Wang J.-Y. |
臺大學術典藏 |
2020-03-31T08:54:34Z |
Apoptosis-associated biomarkers in tuberculosis: Promising for diagnosis and prognosis prediction
|
Yang P.-C.; LI-NA LEE; Yu C.-J.; Shu C.-C.; Wu M.-F.; Hsu C.-L.; Huang C.-T.; Wang J.-Y.; Hsieh S.-L. |
臺大學術典藏 |
2020-03-31T08:54:31Z |
Tuberculosis mortality: Patient characteristics and causes
|
LI-NA LEE; Cheng W.-C.; Chen J.-M.; Hsu C.-L.; Wang J.-Y.; Kuo Y.-W.; Lin C.-J.; Lin C.-H. |
臺大學術典藏 |
2020-03-31T08:54:29Z |
Gender-Dimorphic Impact of PXR Genotype and Haplotype on Hepatotoxicity During Antituberculosis Treatment
|
Wang J.Y.; Tsai C.H.; Lee Y.L.; LI-NA LEE; Hsu C.L.; Chang H.C.; Chen J.M.; Hsu C.A.; Yu C.J.; Yang P.C. |
臺大學術典藏 |
2020-03-31T08:54:29Z |
Comparison of the prevalence of latent tuberculosis infection among non-dialysis patients with severe chronic kidney disease, patients receiving dialysis, and the dialysis-unit staff a cross-sectional study
|
LI-NA LEE; Wang J.-T.; Yu C.-J.; Yang F.-J.; Wu V.-C.; Wang J.-Y.; Lee C.-Y.; Shu C.-C.; Hsu C.-L. |
臺大學術典藏 |
2020-03-31T08:54:28Z |
Risk of tuberculosis among patients on dialysis
|
Yu C.-J.; LI-NA LEE; Chen J.-S.; Wang J.-Y.; Yang F.-J.; Lin H.-H.; Wu V.-C.; Liou H.-H.; Lee C.-Y.; Wei Y.-F.; Hsu C.-L.; Shu C.-C. |
臺大學術典藏 |
2020-03-31T08:54:27Z |
The trend and the disease prediction of vascular endothelial growth factor and placenta growth factor in nontuberculous mycobacterial lung disease
|
Lin C.-H.; Shu C.-C.; Hsu C.-L.; Cheng S.-L.; Wang J.-Y.; Yu C.-J.; LI-NA LEE |
臺大學術典藏 |
2020-03-31T08:54:27Z |
Inflammatory markers and clinical characteristics for predicting persistent positivity of interferon gamma release assay in dialysis population
|
LI-NA LEE; Yu C.-J.; Yang F.-J.; Wang J.-Y.; Wu V.-C.; Lee C.-Y.; Hsu C.-L.; Shu C.-C. |
臺大學術典藏 |
2020-03-30T08:50:44Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Yu C.-J.; Yang J.C.-H.; Shih J.-Y.; Lin Z.-Z.; Lee J.-H.; Chen K.-Y.; Yang C.-Y.; Hsu C.-L.; Ho C.-C.; Lin Y.-T.;Jin-Shing Chen;Liao W.-Y.;Ho C.-C.;Hsu C.-L.;Yang C.-Y.;Chen K.-Y.;Lee J.-H.;Lin Z.-Z.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Lin Y.-T.; JIN-SHING CHEN; Liao W.-Y. |
臺大學術典藏 |
2020-03-27T05:30:03Z |
Adding moxifloxacin is associated with a shorter time to culture conversion in pulmonary tuberculosis
|
Yang P.-C.; Lee L.-N.; PO-REN HSUEH; Yu C.-J.; Hsu C.-L.; Wang J.-T.; Tsai T.-H.; Wang J.-Y.; Yang P.-C.;Lee L.-N.;PO-REN HSUEH;Yu C.-J.;Hsu C.-L.;Tsai T.-H.;Wang J.-T.;Wang J.-Y. |
臺大學術典藏 |
2020-03-23T05:53:56Z |
Quantitative Proteomics of Th-MYCN Transgenic Mice Reveals Aurora Kinase Inhibitor Altered Metabolic Pathways and Enhanced ACADM to Suppress Neuroblastoma Progression
|
Juan H.-F.; Huang H.-C.; Hsu W.-M.; CHIUNG-NIEN CHEN; Chen S.-F.; Yang T.-S.; Huang C.-T.; Hsu C.-L.; Hou C.-L.; Liu Y.-L.; Cheung C.H.Y.; Hsieh C.-H.; Hsieh C.-H.;Cheung C.H.Y.;Liu Y.-L.;Hou C.-L.;Hsu C.-L.;Huang C.-T.;Yang T.-S.;Chen S.-F.;Chiung-Nien Chen;Hsu W.-M.;Huang H.-C.;Juan H.-F. |
臺大學術典藏 |
2020-03-07T06:56:14Z |
Histologic Transformation in a Patient with Lung Cancer Treated with Chemotherapy and Pembrolizumab
|
Hsu C.-L.;Chen K.-Y.;Kuo S.-W.;Yih-Leong Chang; Hsu C.-L.; Chen K.-Y.; Kuo S.-W.; YIH-LEONG CHANG |
臺大學術典藏 |
2020-03-07T06:56:12Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Yih-Leong Chang;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; YIH-LEONG CHANG; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
臺大學術典藏 |
2020-03-07T06:56:11Z |
IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer
|
Tsai M.-F.; Liu Y.-N.; Hsu C.-L.; YIH-LEONG CHANG; Yu C.-J.; Shih J.-Y.; Wu S.-G.;Chang T.-H.;Tsai M.-F.;Liu Y.-N.;Hsu C.-L.;Yih-Leong Chang;Yu C.-J.;Shih J.-Y.; Wu S.-G.; Chang T.-H. |
臺大學術典藏 |
2020-03-07T06:56:09Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Yih-Leong Chang;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
臺大學術典藏 |
2020-03-06T08:24:45Z |
Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma
|
Shen Y.-C.;Hsu C.-L.;Yung-Ming Jeng;Ho M.-C.;Ho C.-M.;Yeh C.-P.;Yeh C.-Y.;Hsu M.-C.;Hu R.-H.;Cheng A.-L.; Shen Y.-C.; Hsu C.-L.; YUNG-MING JENG; Ho M.-C.; Ho C.-M.; Yeh C.-P.; Yeh C.-Y.; Hsu M.-C.; Hu R.-H.; Cheng A.-L. |